Saol Therapeutics

CYTOGAM

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Saol Therapeutics

Cytogam HCPCS:

J0850

HCPCS Code Descriptor:

Injection, cytomegalovirus immune globulin intravenous (human), per vial

Category:

J Code

Cytogam NDCs:

49591-0532-51

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Cytogam CPT Codes:

Potential CPT administration codes for Cytogam can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cytogam:

CYTOGAM is an Oncology drug manufactured by Saol Therapeutics and administered via the Intravenous route of administration. The J Code: J0850 is aligned to the drug CYTOGAM.

ACCESS PRICING AND MORE BY REGISTERING

J0850 Added Date:

January 1, 1982

J0850 Effective Date:

January 1, 1997

J0850 Termination Date:

HCPCS Active

Cytogam billing and coding information can be found through Saol Therapeutics at the link below:
Our team did not identify a source for Cytogam patient assistance information. Please reach out to our team if you feel that this is a mistake.
CYTOGAM prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for CYTOGAM. Please check back in a few weeks.